DigestRedComo funciona
Red
/
Empresas
Bi
No verificado

Biogen Inc.

Sobre qué escribimos

Anuncios brevesBiotecnologíaFinanzasGestión empresarial/Administración de EmpresasMedicina Salud Bienestar

64 Comunicados de prensa

Ver todos los comunicados de prensa
20/04/2026
Biotecnología
Gestión empresarial/Administración de Empresas
Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
31/03/2026
Biotecnología
Biogen to Acquire Apellis, Enhancing the Company’s Growth Portfolio in Immunology and Rare Disease, Bolstering Growth Outlook and Accelerating Expansion into Nephrology
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
30/03/2026
Biotecnología
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
28/03/2026
Biotecnología
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
19/03/2026
Biotecnología
Medicina Salud Bienestar
Biogen to Present New Late-Breaking Litifilimab Phase 2 AMETHYST Data in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
11/03/2026
Biotecnología
Medicina Salud Bienestar
Anuncios breves
Biogen Presents Additional Salanersen Data Showing New Motor Milestones Achieved in Children with SMA Previously Treated with Gene Therapy
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
05/03/2026
Biotecnología
Medicina Salud Bienestar
Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
04/03/2026
Biotecnología
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
11/02/2026
Biotecnología
Biogen Announces Board Chair Transition
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0
04/02/2026
Biotecnología
Medicina Salud Bienestar
Nature Medicine Publishes Results from the Pivotal DEVOTE Study of High-Dose Regimen of Nusinersen in Spinal Muscular Atrophy
Fuente
Biogen Inc.
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0